Previous Article | Next Article ![]()
Journal of Bacteriology, September 2006, p. 6277-6285, Vol. 188, No. 17
0021-9193/06/$08.00+0 doi:10.1128/JB.00591-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Olivier Fayet,3
Marc Dreyfus,1 and
Sylvie Hermann-Le Denmat1*
Laboratoire de Génétique Moléculaire, École Normale Supérieure-CNRS UMR 8541, Paris, France,1 Génétique Moléculaire, Evolutive, et Médicale, INSERM U571, Université Paris V, Paris, France,2 Laboratoire de Microbiologie et Génétique Moléculaires, Université Paul Sabatier-CNRS UMR 5100, Toulouse, France3
Received 26 April 2006/ Accepted 26 May 2006
|
|
|---|
|
|
|---|
Two of these determinants have been particularly well characterized. One is the binding site for ribosomal protein S1. Many TIRs carry short U- or A/U-rich nucleotide stretches upstream of the initiation codon that have a positive effect on translation, presumably because they bind protein S1 (4, 37, 44). Another, particularly important determinant of translation initiation is mRNA structure. Structure can inhibit translation by hampering the access of the 30S ribosomal subunit to its binding site (ribosome binding site [RBS]) within the TIR (9, 29). The affinity of the 30S subunit for the RBS is large enough to iron out weak mRNA structures, and indeed one of the roles of the SD-ASD interaction might be to provide energy for this process (8, 40), but beyond a stability threshold an inverse correlation exists between structure stability and translation efficiency (9). However, secondary structures within the RBS do not invariably depress translation; in some cases, their effect is neutral, presumably because they do not compromise the interaction between the mRNA and the 30S subunit. Such noninhibitory structures have been found upstream of the SD (36), between the SD and the initiation codon (16, 30, 33), or downstream of the start codon (33). That secondary structures can be accommodated by the ribosome illustrates the fact that the mRNA does not necessarily bind continuously to the ribosomal mRNA track, a feature recently documented by structural studies (21).
The TIR of the E. coli rpsA gene, encoding ribosomal protein S1, illustrates an unusual situation where the local mRNA structure is not only noninhibitory but even instrumental to translation initiation (3). This TIR is extremely efficient despite of the absence of a canonical SD element: it carries only a vestigial SD (GAAG) that is not essential for activity. Among its unique characteristics is its lengthit extends as far as 91 nucleotides (nt) upstream from the AUG start codon-and its structure. Indeed, it can fold into three successive hairpins (named I, II, and III from 5' to 3') (Fig. 1) separated by two A/U-rich single-stranded regions (named ss1 and ss2) (2, 3). Hairpins I and II are very stable, whereas hairpin III, which contains the initiator codon in the apical loop and the vestigial SD in the stem, is less so (Fig. 1). This phylogenetically conserved structure is required for the high translational activity of the TIR in E. coli, as well as for the autoregulation exerted by the ribosomal protein S1 on its own translation (3, 41). Presumably, the specific folding of the rpsA TIR generates an optimal spatial arrangement of sequence elements that interact with the 30S ribosomal subunit (3).
![]() View larger version (16K): [in a new window] |
FIG. 1. (Top) Secondary structure of E. coli rpsA TIR and site-directed mutations introduced in the sequence. The TIR is folded in three successive hairpins (I, II, and III) separated by single-stranded regions (ss1 and ss2), as determined by chemical probing experiments and phylogenetic comparisons (3). The online mfold (version 3.1) computer program (26, 45) predicts energy parameters of 10.8, 11.4, and 2.7 kcal/mol for hairpins I, II, and III, respectively. The sequence is numbered from the first base of the initiator codon; mutated positions are in boldface. (Bottom) For each mutated rpsA TIR used in this work, the combined mutations are listed according to their position in the sequence. A dash indicates a sequence identical to the wild-type (WT) sequence.
|
![]() View larger version (17K): [in a new window] |
FIG. 2. (A) The genetic system used here. Plasmid and E. coli chromosomes are schematically shown as large rectangles. The plasmid-borne rrnB operon (gray boxes) is under control of the arabinose-inducible PBAD promoter. Sequences of the anti-SD borne by the pASDWT and pASDmut plasmids are indicated. Only one of the seven chromosomal rrn operons is represented (open boxes), along with the IPTG-inducible lacZ chromosomal fusion used as the translational reporter (hatched and closed boxes). (B) Schematic representation of the rpsA TIR, indicating possible base pairings with the wild-type (ASDWT) or specialized (ASDmut) ASD. The upper drawing corresponds to the wild-type TIR, whereas in the lower one the GGA motifs in loops I and II are changed to CCU. Additional mutations introduced in each TIR are indicated below the sequence. For clarity, the weak hairpin III is represented unfolded.
|
|
|
|---|
12 (11) was used for the construction of all chromosomal rpsA-lacZ and galE-lacZ fusions. This strain carries a short chromosomal deletion of the promoter and the RBS of the lacZ gene (nucleotides 52 to +20 [all numberings refer to the first base of the initiation codon]). Strains DH5
(supE44
lacU169(
80 lacZ
M15) hsdR17 recA1 endA1 gyrA96 thi-1 relA1) or XL1-Blue (supE44 hsdR17 recA1 endA1 gyrA46 thi relA1 lac F' [proAB+ lacIq lacZ
M15 Tn10 (Tetr)]) were used for plasmid propagation.
Construction of rpsA-lacZ and galE-lacZ translational fusions.
Plasmid pES191 is a pEMBL
46 derivative (11) that carries a translational fusion between the wild-type rpsA TIR sequence (nucleotides 91 to +57) and the 5' coding sequence of the lacZ gene (nucleotides +22 to +204) (3). This plasmid was used to introduce deletion and simple or multiple mutations in the rpsA TIR by using either DpnI mutagenesis (Stratagene) or PCR fusion mutagenesis with appropriate designed oligonucleotides. Combined mutations were introduced by successive mutagenesis of various pES191 derivatives. All resulting plasmids were checked by sequencing and then used to transfer the mutated rpsA-lacZ fusion onto the chromosome of HfrG6
12 by homologous recombination (11). The resulting HfrG6
12 derivatives were checked by sequencing of PCR-amplified chromosomal fragments encompassing the rpsA-lacZ fusion regions.
Similarly, plasmid p
46galEWT is a pEMBL
46 derivative that carries a translational fusion between wild-type galE RBS sequence (nucleotides 35 to +28) and the 5' coding sequence of the lacZ gene (43). Alteration of the galE SD from GGAG(C) to CCUCC was achieved by cloning two annealed oligonucleotides encompassing the galE RBS into appropriate BamHI and PstI sites of pEMBL
46 to yield p
46galECCUCC. Wild-type and mutated galE-lacZ fusions were transferred onto the chromosome of HfrG6
12 as described above.
Specialized ribosome system.
The specialized ribosome system is carried by the kanamycin-resistant plasmids pOFX503 and pOFX504. These p15A derivatives (Kanr) contain arabinose-inducible rrnB operons encoding 16S rRNA with wild-type (caCCUCCuua) or mutated (caGGAGGuua) anti-SD, respectively. Briefly, the rrnB operon was first cloned as three separate PCR fragments, and a restriction site was added after the end of the 16S rRNA gene to allow convenient substitutions in the anti-SD by using oligonucleotide cloning (details are available on request). Plasmids pOFX503 and pOFX504 were further modified by PCR fusion mutagenesis to introduce a C
T transition at position 1192 of the 16S rRNA, yielding pASDWT and pASDmut, respectively (Fig. 2A). The C1192T mutation confers spectinomycin resistance (38). These modified plasmids were checked by sequencing and used in all experiments.
Detection of plasmid-encoded 16S rRNA.
The C1192T mutation was used to differentiate plasmid-encoded and chromosome-encoded 16S rRNA in total cellular RNA by using primer extension (38) (Fig. 3A and B). The strain containing the wild-type galE-lacZ chromosomal fusion was used for this purpose (no IPTG [isopropyl-ß-D-thiogalactopyranoside] was added so that the fusion remains uninduced). Cells transformed with either the pASDWT or pASDmut plasmid were grown at 37°C in LB medium supplemented with kanamycin (50 µg/ml). After treatment with arabinose (0.2% final concentration) for the indicated time, cells were collected (optical density at 600 nm [OD600] of 0.5 to 0.6) and total RNA was extracted with acidic phenol. For primer extension, 0.5 µg of total RNA was annealed with 0.2 pmol of
-33P-labeled A16S-1210 primer (5'-GGGCCATGATGACTTGA-3'). Reactions were performed in the presence of ddGTP (2.5 mM) instead of dGTP as described previously (38) so that extension stops at the positions indicated in Fig. 3A. After separation on a 12% polyacrylamide-urea gel, the radioactivity present in the 39- or 19-nt extension products (Fig. 3A and B) was quantified with a FLA3000 PhosphoFluoImager (Fuji) (Table 1).
![]() View larger version (63K): [in a new window] |
FIG. 3. Expression and translational activity of specialized ribosomes. (A) The plasmid-encoded rRNA, which carries the C1192U mutation, can be distinguished from chromosome-encoded rRNA by primer extension. The relevant 16S rRNA region is illustrated, together with the 17-mer used as a primer (dotted arrow). In the presence of ddGTP (see Materials and Methods), primer extension on chromosome and plasmid-encoded 16S rRNA yields an extra 19 or 39 nt, respectively. (B) Upper panel, polysome profile from cells growing in LB medium and expressing plasmid-derived ribosomes. Equivalent profiles were obtained for cells harboring either pASDWT or pASDmut. The 30S, 50S, 70S, and polysome peaks are indicated. Lower panel, primer extension analysis on equal amounts of RNAs from the fractions indicated on the profile. Quantification is presented in Table 1. ni, total RNA from cells in which the expression of plasmid-derived ribosomes was not induced. (C) Left panels, 2D electrophoresis of proteins from cells grown in LB medium and expressing rRNA from plasmid pASDWT (upper panel) or pASDmut (lower panel). Only parts of the gels are shown. Right panel, compared intensities of 178 Coomassie blue-stained spots from the two gels shown (abscissa, pASDWT; ordinate, pASDmut). The solid and dashed lines parallel to diagonal correspond to twofold and fourfold differences between the two gels, respectively. (D) Like ASDWT ribosomes, ASDmut ribosomes can translate bulk cellular mRNAs in the absence of cellular ribosomes, although the resulting protein pattern is not identical in both cases. Cells growing in minimal medium in the presence of arabinose were treated with spectinomycin (Spec.) and then pulse-chased with [35S]methionine either immediately (0 min) or after 30 min. Asterisks and diamonds indicate proteins that are preferentially synthesized by ASDWT or ASDmut ribosomes, respectively. "Control" refers to cells carrying a pASDWT derivative lacking the C1192T mutation conferring spectinomycin resistance. Molecular masses are given in kDa.
|
|
View this table: [in a new window] |
TABLE 1. Distribution of plasmid-encoded 16S rRNA in the 30S subunit, the 70S particle, and polysomes
|
Measurement of ß-galactosidase activity. For measurement of ß-galactosidase activity, cells were grown as described above and activity was assayed as described previously (2). Each measurement was done at least in triplicate. For each assay of ASDWT or ASDmut ribosomes, cultures were treated for at least 2 h with arabinose (0.2%), and then IPTG (500 µM) was added to induce the lac operon. Incubation was continued for an additional 30 min before harvesting of cells.
2D gel electrophoresis. Cells were grown in 20 ml of LB supplemented with arabinose (0.2%) and kanamycin (50 µg/ml) and harvested at an OD600 of 0.5. Pellets were treated with Bugbuster (Novagen) supplemented with Complete EDTA-free protein inhibitors (Roche), 1 unit/ml benzonase, and 400 µg/ml lysozyme, according to the manufacturer's protocol (Novagen). Soluble proteins (500 µg) were resuspended in 400 µl of solubilization buffer {8 M urea, 2% 3-[(3-cholamidopropyl)-dimethylammonio]-1-propanesulfonate (CHAPS), 40 mM dithiothreitol} and analyzed by two-dimensional (2D) gel electrophoresis (first dimension, Immobiline DryStrip, pH 4 to 7 [Amersham]; second dimension, 10% acrylamide-sodium dodecyl sulfate gel). Gels were stained with Coomassie blue G250 and scanned on a GS-800 imaging densitometer (Bio-Rad). Individual spots were quantified with PDQuest software for 2D analysis (Bio-Rad).
In vivo protein labeling. Cells were grown in M63 minimal medium (28) supplemented with vitamin B1 (0.05%), histidine (0.01%), glycerol (0.9%), and kanamycin (50 µg/ml) to an OD600 of 0.15 to 0.2. Cultures were then supplemented with arabinose (0,2%) and, after 3 hours, with spectinomycin (500 µg/ml). Aliquots (0.5 ml) were labeled with 50 µCi of [35S]Met/Cys (Pro-Mix; Amersham) either immediately or 30 min after spectinomycin addition. Labeling was stopped after 1 min with excess cold Met and Cys. Cells were harvested, lysed by sonication, and analyzed on a 10% NuPage gel (Invitrogen).
Lead(II) acetate probing of rpsA mRNA.
Probing was performed on 157-nt-long, in vitro-transcribed RNA fragments encompassing the (loopI+IIWT,AUG) (WT) or (loopI+IImut,AUG) rpsA TIRs. These fragments span nt 91 to +57 of the rpsA mRNA with a GGATCCGTC extension at the 5' end. Templates for transcription were PCR amplified from pES191 or its (loopI+IImut,AUG) derivative, using primers 5'-TAATACGACTCACTATAGGATCCGTCCCCCGTTGC-3' (upstream primer; the T7 RNA polymerase promoter is underlined) and 5'-GCGGGTTTCGATTTCTTTTAAGG-3' (downstream primer). Transcription was carried out according to the Ambion MEGAshortscript protocol with [
-32P]UTP as a tracer and guanosine (20 mM) as the initiator nucleotide. The latter allows subsequent RNA 5' end labeling without dephosphorylation. RNA was gel purified, eluted, and resuspended in water; its concentration was estimated from the amount of 32P incorporated. Ten picomoles of each transcript was then 5' end labeled with [
-33P]ATP and subsequently purified on ProbQuantG50 microcolumns (Pharmacia). The protocol for lead(II)-mediated cleavage was adapted from published methods (18, 24). Briefly, cleavage was performed with 50,000 cpm of 5'-labeled RNA in the presence of 2 µg of yeast tRNA (Sigma) in 50 mM Tris acetate, 5 mM Mg-acetate, and 50 mM K-acetate. Prior to lead(II) acetate addition, labeled RNA was heated at 65°C for 5 min and then slowly (80 min) cooled to 20°C. Reactions were performed in a final volume of 10 µl for 10 min at 20°C and stopped by adding 1 µl of 0.5 M EDTA. Control samples were treated similarly but without lead(II). RNA was then precipitated and analyzed on an 8% polyacrylamide gel with 7 M urea. A ladder obtained by partial alkaline hydrolysis of the same RNA was run in parallel; for this purpose, labeled RNA (50,000 cpm) was incubated for 1 min at 90°C in 50 mM Na2CO3-50 mM NaHCO3 (pH 9) in the presence of 2 µg yeast tRNA.
|
|
|---|
The specialized ribosome system consists of two p15A-based plasmids (10 to 12 copies/cell) carrying the rrnB operon under the control of an arabinose-inducible promoter (Fig. 2A). In one of them (hereafter referred to as pASDWT), the anti-SD is wild type, whereas in the other (pASDmut) it has been changed from CCUCCUUA-3' to GGAGGUUA-3' (Fig. 2A). Ribosomes containing the modified 16S rRNA should recognize the altered SD CCUCC. In order to tag plasmid-encoded rRNA within the ribosome population, a C
T transition was introduced in both plasmids at position 1192 of 16S rRNA (see Materials and Methods). This mutation, which also confers spectinomycin resistance, can be used to differentiate plasmid-encoded from chromosome-encoded 16S rRNA by primer extension (38) (Fig. 3A). For simplicity, "ASDWT" and "ASDmut" are used hereafter to designate rRNAs from plasmids pASDWT and pASDmut, respectively, or more generally for ribosomes or cells that contain these rRNAs. In contrast, "cellular" is used to designate chromosome-encoded 16S rRNA or the ribosomes that contain it.
Specialized ribosomes can translate bulk cellular mRNA. To monitor the effect of specialized ribosomes on cell physiology, cells containing plasmid pASDWT or pASDmut were grown in LB medium, and arabinose was added in log phase to induce expression of the plasmidic rrnB operon. After 2 h of induction, this expression, quantified by primer extension, reached a plateau corresponding to 35 to 38% of total 16S rRNA (Table 1); the value for ASDmut rRNA is consistently slightly lower than for ASDWT, perhaps indicating some instability of the former rRNA in vivo. Importantly, induction did not compromise steady-state growth. With ASDWT rRNA the growth rate was unaffected, whereas with ASDmut it was depressed by only ca. 10%, indicating that protein synthesis is not severely impaired (data not shown). To assess whether ASDmut rRNA is incorporated into active ribosomes, its distribution into the 30S subunit, the 70S particle, and polysomes was determined. To this end, cell extracts were fractionated on sucrose gradients, and the 16S rRNA population from individual fractions was analyzed (Fig. 3A and B). As expected, the ASDWT 16S rRNA was efficiently incorporated in polysomes; however, quantitatively, its relative abundance in polysomes was only 80% of that in 30S subunits (i.e., ca. 30/38) (Table 1), possibly indicating that, functionally, the C1192T mutation is not completely neutral (10, 35). Surprisingly, the ASDmut 16S rRNA was also well represented in polysomes (Fig. 3B), with a proportion that reached ca. 45% of that in 30S subunits (i.e., 15/33) (Table 1). Obviously, ribosomes bearing ASDmut are not strongly counterselected for translation, even though the cells contain no engineered mRNA with a complementary SD.
To determine whether ASDmut ribosomes participate normally in cellular translation, protein extracts from ASDWT or ASDmut cells were compared by 2D gel electrophoresis (Fig. 3C). Quantification of 178 spots from Coomassie blue-stained gels showed that the two protein profiles were similar, with only 10% of the spots differing more than twofold in intensity between the two strains (Fig. 3C). The scarcity of ASDmut-specific spots on the 2D gels suggests that ASDmut ribosomes do not concentrate on a few specific mRNAs but participate in the translation of many, and perhaps most, well-translated cellular mRNAs.
The above conclusion seems at odd with previous work showing that ribosomes carrying mutated ASDs, including the ASDmut sequence used here (system IX in reference 17) cannot translate cellular mRNAs normally (17, 20). A distinctive feature of these former studies compared to the present one is that the proportion of mutated versus cellular ribosomes was much higher. To test whether this higher proportion might explain the difference, we exploited the fact that in the presence of spectinomycin, cellular ribosomes are inactivated so that ASDWT or ASDmut ribosomes now constitute 100% of the ribosomes active in the cell. With the spectinomycin concentrations required to inhibit cellular ribosomes almost completely (i.e., 500 µg/ml), neither ASDWT nor ASDmut cells could achieve steady-state growth, perhaps because the concentration of spectinomycin-resistant ribosomes in the cell is insufficient. Nevertheless, protein synthesis in the two strains could be compared by adding the drug to growing cells and then pulse-labeling them with [35S]methionine (see Materials and Methods). As expected, with ASDWT cells, protein synthesis was reduced but still observable in the presence of the drug. Interestingly, the same hold true also for ASDmut cells (Fig. 3D). Comparison of the two protein profiles shows a few individual species that are synthesized mainly or exclusively either by the ASDWT or the ASDmut ribosomes, together with a background that appears similar in the two cases (Fig. 3D). Altogether, quantification showed that, in the presence of spectinomycin, 35S incorporation in ASDmut cells was quite significant (ca. 50%) compared to that in ASDWT cells, confirming that ASDmut ribosomes can translate bulk cellular mRNAs.
In the past, specialized ribosomes have been assayed either under conditions illustrated above, i.e., moderate expression allowing steady-state growth (1, 23, 31), or under conditions of high expression and/or selective inactivation of cellular ribosomes, allowing only transient studies (5, 15, 17, 20). The former conditions have been preferred here, since steady-state conditions appear more physiologically relevant. Since ASDmut ribosomes are then assayed in the presence of excess cellular ribosomes, their preferential utilization by a given TIR is detected as an increase in TIR activity over a nonzero background due to cellular ribosomes. Previously, this background has been taken as the activity of the TIR prior to induction of the specialized system (23, 31). For greater consistency, the activity of the TIR in the presence of ASDWT ribosomes is used here for this purpose.
ASDmut ribosomes preferentially translate an mRNA with a complementary SD. The specificity of the ASDmut ribosomes was first evaluated with lacZ chromosomal fusions carrying the TIR from the galE gene. This particular TIR was chosen because its activity is stringently dependent upon the SD-ASD interaction (43). The galE SD, GGAG(C), was mutated to CCUCC, and strains carrying the wild-type or mutated galE TIR were then transformed with plasmid pASDWT or pASDmut. After at least 2 hours of arabinose induction so that the concentration of plasmid-derived ribosomes reached a plateau, the lac operon was induced with IPTG and ß-galactosidase expression was measured.
The activity of the wild-type galE TIR was high and was nearly identical whether ASDWT or ASDmut ribosomes were present (Fig. 4A). Concerning the mutant TIR, its activity was very low in the presence of ASDWT ribosomes (ca. 1.5% of the wild-type value), consistent with the known stringency for SD-ASD interaction in this case. In the presence of ASDmut ribosomes, this low activity was stimulated
6-fold. Yet, activity still amounted to only 10% of the activity of the wild-type TIR. It is possible that compared with the wild-type TIR, the mutant TIR adopts a structure less favorable for ribosome binding. Alternatively, specialized ribosomes may be less efficient than the wild-type ribosomes for recognizing their cognate SD; one obvious reason is their lower concentration in the cytosol, which may not be enough to saturate the TIR. In any case, this experiment shows that the ASDmut ribosomes can indeed recognize the modified SD, CCUCC.
![]() View larger version (24K): [in a new window] |
FIG. 4. Histograms showing ß-galactosidase activities from the indicated TIR-lacZ translational fusions in the presence of ASDWT or ASDmut ribosomes. ß-Galactosidase units correspond to nanomoles of o-nitrophenyl-ß-D-galactopyranoside hydrolyzed per min and per mg of total protein. The values shown are averages from at least three independent assays. (A) ß-Galactosidase expression from the galEWT and galECCUCC TIRs. (B) ß-Galactosidase expression from various mutants of the rpsA TIR. The different TIRs contain either the wild-type GGA motifs (loopI+IIWT) (upper panel) or the mutant CCU motifs (loopI+IImut) (lower panel) in loops I and II, together with the indicated additional mutations (see Fig. 1). Note the different scales of individual histograms. Error bars indicate standard deviations.
|
CCU replacement in loop I (result not shown) or than individual GG
AU replacements in either loop (3). The fact that alterations in either conserved GGA motif, or in both of them, affect translation to the same extent supports the view that these motifs work together for optimal TIR activity. Plasmid pASDWT or pASDmut was then introduced into the strains carrying either the wild-type or the (loopI+IImut,AUG) TIR, and the activities of the TIRs were evaluated as described above. Like for the wild-type galE TIR, the activity of the wild-type rpsA TIR was not significantly different in the presence of either type of ribosome (Fig. 4B). In contrast, the activity of the (loopI+IImut,AUG) TIR was higher in the presence of the ASDmut ribosomes, showing that the latter use the mutated TIR more efficiently than the ASDWT ribosomes. Yet the effect (1.3-fold) was far more modest than that with the galE TIR (6-fold). An obvious reason for this smaller effect was that the (loopI+IImut,AUG) TIR still used wild-type ribosomes fairly efficiently; its activity in the presence of ASDWT ribosomes was only threefold lower than that of the wild-type TIR. We therefore attempted to further manipulate the TIR so that its activity with wild-type ribosomes becomes more stringently dependent upon the presence of the GGA elements. To this end, the rpsA initiation codon was changed to GUG or UUG. The rationale here is that when the initiation codon is changed from an AUG to a non-AUG codon, the activity of the TIR generally becomes more dependent upon other elements, i.e., the SD or translational enhancers (34).
In the presence of ASDWT ribosomes, changing the initiation codon AUG to GUG, and, even more so, to UUG, affected the activity of the TIR very negatively (by as much as 45-fold for UUG) (Fig. 4B). Importantly, this activity was now more dependent upon the presence of the GGA motifs in loops I and II; when the initiation codon was GUG or UUG, the introduction of the (loopI+II) mutation reduced TIR activity about sixfold, instead of threefold when the initiation codon was AUG (Fig. 4B). Like for the wild-type rpsA TIR, the presence of ASDmut ribosomes had little effect on the activity of the (loopI+IIWT,GUG) or (loopI+IIWT,UUG) TIR. In contrast, when the loopI+II mutation was also present, ASDmut ribosomes stimulated the TIR activity, as for the (loopI+IImut,AUG) TIR. However, stimulation was now larger: the (loopI+IImut,GUG) and (loopI+IImut,UUG) TIRs were stimulated 2- and 4.5-fold, respectively, versus 1.3-fold for the (loopI+IImut,AUG) TIR (Fig. 4B).
Whereas these results show that rpsA TIRs carrying the loopI+II mutation are preferentially recognized by ASDmut ribosomes, they do not prove that this recognition reflects a pairing with the apical CCU motifs. Indeed, we noticed a possible slipped base pairing between the ASDmut and the AACCU sequence present just before hairpin III, at nt 16 to 12 with respect to the initiator codon (Fig. 2B). To clarify the role of this sequence, we either deleted the CC doublet at nt 13 and 14 or replaced it by AU in the (loopI+IImut,UUG) TIR, for which the effect of specialized ribosomes was largest (
CC and CC
AU in Fig. 1 and 4B). As a control, the same mutations were also introduced in the (loopI+IIwt,UUG) TIR. In all cases, in the absence of the ASDmut ribosomes, alterations of the CC doublet significantly increased ß-galactosidase synthesis, indicating that the CC doublet acts as a negative element in the rpsA TIR. More importantly, these alterations also completely abolished the stimulation of the (loopI+IImut,UUG) TIR by ASDmut ribosomes (Fig. 4B). This result indicates that the observed stimulation reflects the presence of a spurious SD-like sequence that can pair with the ASDmut; in its absence, the loopI+II-mutated TIR is not stimulated by ASDmut ribosomes.
This lack of stimulation may reflect a conformational difference between the loopI+IIWT and loopI+IImut TIRs that renders the CCU trinucleotides unavailable for pairing. However, the mfold algorithm (26, 45) predicts that the secondary structure of the rpsA TIR does not vary upon changing the GGA triplets to CCU. To further document this point, the in vitro structures of the wild-type and (loopI+IImut,AUG) TIRs were probed with lead(II). This reagent preferentially recognizes and cleaves single-stranded regions, largely independently of their sequence (18, 24). Consistent with theoretical predictions, this technique revealed no difference in structure between the wild-type and loopI+IImut TIRs (Fig. 5). In particular, the CCU triplets appear to be fully accessible in the mutant.
![]() View larger version (48K): [in a new window] |
FIG. 5. Compared patterns of lead(II)-induced cleavages in rpsA TIRs carrying either loopI+IIWT or loopI+IImut (Fig. 1). (A) In vitro-transcribed wild-type (WT) and (loopI+IImut,AUG) TIRs were probed with 60, 80, and 100 mM lead(II). Ctr, control without lead(II). L, alkaline hydrolysis ladder. Positions of the stem-and-loop regions of hairpins I and II and of single stranded regions (ss1 and ss2) are indicated. The smaller panels (right) focus on the apical loops of hairpins I and II; the relevant sequence is indicated on the right side, and uppercase is used for nucleotides from the loops. (B) The cleavage pattern of the region encompassing hairpins I and II is represented on the secondary structure model of the rpsA TIR (3). Strong, average, and weak cleavages are indicated by black, gray, and dotted arrows, respectively.
|
|
|
|---|
Why, then, are the apical GGA motifs required for high translational activity? They may constitute interacting sites for regions of 16S rRNA other than the anti-SD or for a protein(s) from the translational machinery. Among the latter, one candidate is protein S1 itself. Ribosome-bound S1 is essential for the translation of most or all cellular mRNAs (39). Intriguingly, the RNA aptamer that binds S1 most tightly consists of a pseudoknot carrying a GGA motif in one of its loops (32). We speculate that, analogously, the GGA motifs from loops I and II may constitute recognition sites for ribosome-bound S1, allowing the correct positioning of the initiator codon to the P site. That purine-rich loops may constitute S1 binding sites has been suggested by others (40). Interestingly, the rpsA TIR is unique in that its activity is strongly repressed by free S1 (autoregulation) (2). Chemical protection analyses have identified ss1, ss2, and part of loop III as targets for free S1, but the binding sites of free S1 and ribosome-bound S1 may not coincide. The susceptibility of the GG residues from both loops I and II to chemical modification increases in the presence of free S1, suggesting that the loops then undergo a conformational change (3). Possibly, this conformational change prevents recognition of the TIR by ribosome-bound S1.
Specialized ribosomes can translate bulk cellular mRNA. Under the conditions used here, the ASDmut 16S rRNA represents ca. 35% of total 16S rRNA, yet growth is not severely affected. This observation is consistent with that of Lee et al. (23), who found that cells expressing the same ASDmut 16S rRNA at a level similar to that used here were viable (clone 6 in reference 23). We also found that the ASDmut ribosomes are fairly efficiently enrolled in translation, even in the absence of a specific, complementary mRNA; their proportion in polysomes reaches 45% of their proportion in free 30S particles. Yet, the pattern of protein synthesized is similar to that observed in cells expressing the ASDWT ribosomes. Together, these two results suggest that ASDmut ribosomes participate in the translation of many cellular mRNAs and that, on the average, they are discriminated against by a factor of only about 2 in translation initiation. This observation was confirmed directly by using conditions where only ASDmut ribosomes (or ASDWT ribosomes) are active, i.e., in the presence of spectinomycin. Under these non-steady-state conditions, the patterns of protein synthesized by the ASDmut and ADSWT ribosomes were not identical, but quantitatively, protein synthesis by ASDmut ribosomes was still about one-half of that for ASDWT ribosomes.
How can ASDmut ribosomes translate bulk cellular mRNAs in the absence of a cognate SD-ASD interaction? A fraction of these mRNAs may spuriously carry SD-like elements with complementarity to ASDmut. The triplets ACC, UCC, and CCU all potentially bind the ASDmut with significant free energy (1.2 to 1.8 kcal/mol [13]). Assuming that these triplets are not discriminated against in natural TIRs, about 50% of the TIRs will, on a random basis, carry one of them 4 to 15 nt upstream of the initiation codon, i.e., in a position where it may act as a minimal SD towards ASDmut ribosomes. As an illustration, the rpsA TIR itself carries an AACCU sequence that apparently can interact proficiently with ASDmut ribosomes (Fig. 4B). Alternatively, it is possible that cellular ribosomes, when present in the cell together with ASDmut ribosomes, can channel them into translation. Indeed, if an essential role of the SD-ASD interaction is to open inhibitory local secondary structures (8, 40), then after initiation by a ribosome with a wild-type ASD, opening may last long enough for ribosomes lacking such an ASD to initiate translation. Finally, it is possible that a significant fraction of all cellular mRNAs relies only marginally, if at all, on the SD-ASD interaction for translation, as exemplified here by the rpsA mRNA itself. Such mRNAs would make no distinction between wild-type and specialized ribosomes. There is, in fact, much evidence supporting the view that the SD-ASD interaction is not always required for efficient translation. In vitro, this interaction is clearly dispensable (6, 27). In vivo, our observation that translation of bulk cellular mRNAs remains significant when only ASDmut ribosomes are active in the cell is not unprecedented (15, 17; see Fig. 5, lanes 6 to 8, in reference 17), although this point was not emphasized in these previous studies. Other arguments support the idea that SD-independent translation is not marginal in E. coli. Although highly expressed genes generally possess stronger SDs than average ones, as many as 12% of E. coli mRNAs lack a recognizable SD (25). Consistent with the dispensability of the SD interaction, artificial mRNAs lacking an SD in their leader sequences (42), and even leaderless mRNAs (22), can be translated in E. coli. Even for TIRs with a bona fide SD, cases are known where alterations in the SD do not abrogate or even do not affect activity, in spite of the loss of the SD-ASD interaction (12, 19, 23). Thus, the situations exemplified here with the galE and rpsA TIRs (stringent dependence or no dependence upon the SD-ASD interaction, respectively) may simply constitute extreme cases of a more common situation where the SD-ASD interaction is only one element among others contributing to translation initiation.
This work is supported by the Centre National de la Recherche Scientifique, by the École Normale Supérieure, and by the Agence Nationale pour la Recherche (grant NT05-1_44659) to M.D. and by fellowships from the French Ministère de l'Éducation Nationale de l'Enseignement Supérieur et de la Recherche (MENESR) and the Fondation pour la Recherche Médicale (FRM) to P.S.
Present address: Department of Cell and Molecular Biology, Molecular Biology Programme, Biomedical Center, Box 596, Husargatan 3, SE-751 24 Uppsala, Sweden. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»